Sanofi (NASDAQ:SNY) and United-Guardian (NASDAQ:UG) Critical Review

Sanofi (NASDAQ:SNY – Get Free Report) and United-Guardian (NASDAQ:UG – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, profitability, analyst recommendations and dividends.

Insider and Institutional Ownership

14.0% of Sanofi shares are owned by institutional investors. Comparatively, 23.2% of United-Guardian shares are owned by institutional investors. 1.0% of Sanofi shares are owned by insiders. Comparatively, 29.0% of United-Guardian shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Sanofi and United-Guardian’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Sanofi 8.70% 15.16% 8.48%
United-Guardian 25.16% 27.84% 23.68%

Volatility and Risk

Sanofi has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500. Comparatively, United-Guardian has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and target prices for Sanofi and United-Guardian, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanofi 0 12 8 1 2.48
United-Guardian 0 1 0 0 2.00

Sanofi presently has a consensus price target of $53.00, indicating a potential upside of 8.78%. Given Sanofi’s stronger consensus rating and higher possible upside, analysts plainly believe Sanofi is more favorable than United-Guardian.

Dividends

Sanofi pays an annual dividend of $1.76 per share and has a dividend yield of 3.6%. United-Guardian pays an annual dividend of $0.60 per share and has a dividend yield of 7.4%. Sanofi pays out 87.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. United-Guardian pays out 88.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. United-Guardian has increased its dividend for 1 consecutive years. United-Guardian is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Earnings & Valuation

This table compares Sanofi and United-Guardian”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sanofi $50.98 billion 2.32 $8.84 billion $2.02 24.12
United-Guardian $10.55 million 3.53 $2.11 million $0.68 11.94

Sanofi has higher revenue and earnings than United-Guardian. United-Guardian is trading at a lower price-to-earnings ratio than Sanofi, indicating that it is currently the more affordable of the two stocks.

About Sanofi

(Get Free Report)

Sanofi is a France-based global biopharmaceutical company that researches, develops, manufactures and markets medicines and vaccines. Its work spans areas including immunology, oncology, rare diseases and neurology, as well as preventive vaccines. The company’s portfolio includes Dupixent, an immunology medicine developed with Regeneron, and vaccines for diseases such as influenza and meningitis. Sanofi serves patients and healthcare providers in markets around the world. Sanofi traces its origins to a company established in France in 1973.

About United-Guardian

(Get Free Report)

United-Guardian, Inc. develops and manufactures specialty products for personal care, pharmaceutical, medical and industrial applications. Its offerings include ingredients used in skin-care and cosmetic formulations, as well as medical products. The company’s product lines include Lubrajel®, a range of water-based gel products used in personal-care and medical applications, and Renacidin®, a prescription irrigation solution. United-Guardian sells its products in the United States and internationally.

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.